FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


19439 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Class Eurotiomycetes Subclass Eurotiomycetidae (organism)
Class Fibrobacteres Class Fibrobacteria
Class Lentisphaerae Class Lentisphaeria (organism)
Class Microsporea Phylum Microsporidia (organism)
Class amphibia Class Amphibia (organism)
Class arachnida Arachnid
Class crustacea Subphylum Crustacea (organism)
Class diplopoda Class Diplopoda (organism)
Classic SEMM laparoscopic hysterectomy Classic intrafascial supracervical hysterectomy (procedure)
Classic mast cell leukemia Mast cell leukemia (clinical)
Clavicular flap Flap (substance)
Clavulanate potassium + ticarcillin disodium gm/gm injection Product containing clavulanic acid and ticarcillin (medicinal product)
Clavulanate potassium gm/ticarcillin disodium gm injection solution vial Product containing clavulanic acid and ticarcillin (medicinal product)
Clean environment Clean environment (finding)
Cleaner for heated surfaces Cleaning agent (substance)
Cleaner for heated surfaces causing toxic effect Cleaning product causing toxic effect
Cleaning material Cleaning agent (substance)
Cleaning of animal penis Cleaning of penis
Clear cell (mesonephroid) neoplasm - category Clear cell mesonephroid neoplasm
Clear cell sarcoma (except of Kidney M-89643) Clear cell sarcoma
Clemastine 1.34mg tablet Clemastine fumarate 1.34 mg oral tablet
Clemastine 500micrograms/5mL elixir Product containing precisely clemastine fumarate 134 microgram/1 milliliter conventional release oral solution (clinical drug)
Clemastine fumarate 0.67mg/5mL syrup Product containing precisely clemastine fumarate 134 microgram/1 milliliter conventional release oral solution (clinical drug)
Clemastine+phenylpropanolamine 0.5/25mg tablet Clemastine fumarate 670 microgram and phenylpropanolamine 25 mg oral tablet
Clemastine+phenylpropanolamine 0.5/25mg tablet Clemastine fumarate 670 microgram and phenylpropanolamine 25 mg oral tablet
Clemmys insculpta Glyptemys insculpta (organism)
Clindamycin 1% topical foam Product containing precisely clindamycin phosphate 10 milligram/1 milliliter conventional release cutaneous foam (clinical drug)
Clindamycin 1.2%/tretinoin 0.025% topical gel Clindamycin phosphate 12 mg/g and tretinoin 250 microgram/g cutaneous gel
Clindamycin 2% cream Product containing precisely clindamycin phosphate 20 milligram/1 milliliter conventional release cutaneous cream (clinical drug)
Clindamycin 75mg/mL oral solution Clindamycin (as clindamycin hydrochloride) 75 mg/mL oral suspension
Clindamycin palmitate hydroc 75 mg/ 5mL suspension Clindamycin (as clindamycin hydrochloride) 75 mg/mL oral suspension
Clindamycin palmitate hydroc 75mg/5mL solution Clindamycin (as clindamycin hydrochloride) 75 mg/mL oral suspension
Clindamycin phosphate 1% solution Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous solution
Clindamycin phosphate 100mg vaginal ovule Product containing precisely clindamycin (as clindamycin phosphate) 100 milligram/1 each conventional release vaginal pessary (clinical drug)
Clindamycin phosphate 10mg solution Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous solution
Clindamycin phosphate 10mg/mL solution Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous solution
Clindamycin phosphate 2% cream Product containing precisely clindamycin phosphate 20 milligram/1 milliliter conventional release cutaneous cream (clinical drug)
Clinical Outcomes in Routine Evaluation Outcome Measure Global Distress score Clinical Outcomes in Routine Evaluation Outcome Measure Global Distress total score
Clinical actions A - G Action
Clinical actions A-O Action
Clinical actions H - O Action
Clinical actions P - S Action
Clinical actions P-Z Action
Clinical actions T - Z Action
Clinical allergy service Clinical allergy service
Clinical cytogenetics service Clinical cytogenetics service (qualifier value)
Clinical finding Clinical finding (finding)
Clinical genetics service Clinical genetics service (qualifier value)
Clinical immunology service Clinical immunology service
Clinical management plan Clinical management plan
Clinical molecular genetics service Clinical molecular genetics service (qualifier value)
Clinical neurophysiology service Clinical neurophysiology service
Clinical stage 0 0
Clinical stage I A IA
Clinical stage I B IB
Clinical stage I C IC
Clinical stage I E IE
Clinical stage I S American Joint Committee on Cancer stage IS (qualifier value)
Clinical stage II A American Joint Committee on Cancer stage IIA (qualifier value)
Clinical stage II B American Joint Committee on Cancer stage IIB (qualifier value)
Clinical stage II C IIC
Clinical stage II E IIE
Clinical stage III A American Joint Committee on Cancer stage IIIA (qualifier value)
Clinical stage III B American Joint Committee on Cancer stage IIIB (qualifier value)
Clinical stage III C American Joint Committee on Cancer stage IIIC (qualifier value)
Clinical stage IV A American Joint Committee on Cancer stage IVA (qualifier value)
Clinical stage IV B IVB
Clinical stage IV C American Joint Committee on Cancer stage IVC (qualifier value)
Clinically relevant enzymes with no Enzyme Commission designation Enzyme
Clipping of organ NOC Closure by clip
Clivogram Plain X-ray of clivus
Clomocycline sodium adverse reaction Adverse reaction to clomocycline
Clonazepam 0.125mg wafer Product containing precisely clonazepam 125 microgram/1 each conventional release orodispersible tablet (clinical drug)
Clonazepam 0.25mg wafer Clonazepam 250 microgram orodispersible tablet
Clonazepam 0.5mg wafer Clonazepam 500 microgram orodispersible tablet
Clonazepam 1mg wafer Clonazepam 1 mg orodispersible tablet
Clonazepam 2mg wafer Clonazepam 2 mg orodispersible tablet
Clopidogrel bisulfate 75mg tablet Product containing precisely clopidogrel (as clopidogrel bisulfate) 75 milligram/1 each conventional release oral tablet (clinical drug)
Clorazepate dipotassium 7.5mg Product containing precisely dipotassium clorazepate 7.5 milligram/1 each conventional release oral tablet (clinical drug)
Closed anterior dislocation of humerus Closed anterior dislocation of glenohumeral joint
Closed cerebral contusion Contusion of cerebral cortex
Closed fracture finger metacarpal shaft Closed fracture of shaft of metacarpal bone
Closed fracture of C1-C4 level with central cord syndrome Central cord syndrome of cervical spinal cord due to closed fracture at C1-C4 level (disorder)
Closed fracture of C1-C4 level with other specified spinal cord injury Closed fracture of C1-C4 level with spinal cord injury (disorder)
Closed fracture of C5-C7 level with central cord syndrome Central cord syndrome of cervical spinal cord due to closed fracture at C5-C7 level (disorder)
Closed fracture of C5-C7 level with other specified spinal cord injury Closed fracture of C5-C7 level with spinal cord injury
Closed fracture of T1-T6 level with central cord syndrome Central cord syndrome of thoracic spinal cord due to closed fracture at T1-T6 level (disorder)
Closed fracture of T1-T6 level with other specified spinal cord injury Closed fracture of T1-T6 level with spinal cord injury
Closed fracture of T7-T12 level with central cord syndrome Central cord syndrome of thoracic spinal cord due to closed fracture at T7-T12 level (disorder)
Closed fracture of T7-T12 level with other specified spinal cord injury Closed fracture of T7-T12 level with spinal cord injury
Closed fracture of base of skull with intracranial injury of other and unspecified nature Closed fracture of base of skull with intracranial injury
Closed fracture of base of skull with other and unspecified intracranial hemorrhage Closed fracture of base of skull with intracranial hemorrhage
Closed fracture of bony thorax part unspecified Closed fracture of bones of trunk
Closed fracture of bony thorax part unspecified Closed fracture of bones of trunk
Closed fracture of cervical region with spinal cord injury Injury of cervical spinal cord due to closed fracture of cervical spine (disorder)
Closed fracture of cervical spine with cord lesion Injury of cervical spinal cord due to closed fracture of cervical spine (disorder)
Closed fracture of cervical spine with spinal cord lesion NOS Injury of cervical spinal cord due to closed fracture of cervical spine (disorder)
Closed fracture of coccyx with spinal cord lesion Closed fracture of coccyx
Closed fracture of lower limb, level unspecified Closed fracture of lower limb
Closed fracture of lower limb, level unspecified Closed fracture of lower limb
Closed fracture of other parts of bony thorax Closed fracture of bones of trunk

Start Previous Page 33 of 195 Next End


Reference Sets

Reference set descriptor

Back to Start